This is going sideways at best until the quarterly at the end of the month. Only if Febridx is producing substantial sales in the US and the $5M cash is showing as received would this occur.
Otherwise, its going to remain stagnant for some time in my opinion now. Its only moving on news and only then the instos who are market makers on this stock let it run. Retailers are not buying in and the minimal trades being seen are likely existing investors averaging down every $500 they can get their hands on.
Add to My Watchlist
What is My Watchlist?
